









시장가
/
주식
/
nasdaq-gild
/

Gilead Sciences Inc

GILD

136.890USD

-1.220-0.88%

종가 03/26, 16:00（ET）시세는 15분 지연됩니다

830.31B시가총액

20.01P/E TTM



Gilead Sciences Inc

136.890

-1.220-0.88%

개요 금융 분석 회사

개요

금융

분석

회사

자세한 내용은 Gilead Sciences Inc 회사

Gilead Sciences, Inc. is a biopharmaceutical company. It is engaged in advancing medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, COVID-19, cancer and inflammation. It is focused on discovering, developing and delivering medicines to address unmet medical needs in virology, oncology and other therapeutic areas. Its portfolio of marketed products includes Biktarvy, Genvoya, Descovy, Complera/Eviplera, Symtuza, Truvada, Stribild, Sunlenca, Epclusa, Vemlidy, Harvoni, Viread, Livdelzi, Veklury, Yescarta, Tecartus, Trodelvy, AmBisome, and Letairis. Its product candidates include Bulevirtide, Lenacapavir, Axicabtagene ciloleucel, Sacituzumab govitecan-hziy, and others. It also develops the HB-400 program and the HB-500 program. It develops therapies that are intended to provide functional cures for hepatitis B virus and human immunodeficiency virus-1. It operates in more than 35 countries worldwide.

Gilead Sciences Inc 정보



종목 코드 GILD

회사 이름Gilead Sciences Inc

상장일Jan 22, 1992

CEOO'Day (Daniel P)

직원 수17600

유형Ordinary Share

회계 연도 종료Jan 22

주소333 Lakeside Dr

도시FOSTER CITY

증권 거래소NASDAQ OMX - NASDAQ BASIC

국가United States of America

우편 번호94404-1147

전화16505743000

웹사이트https://www.gilead.com/

종목 코드 GILD

상장일Jan 22, 1992

CEOO'Day (Daniel P)

Gilead Sciences Inc의 회사 임원진



이름

이름/직위

직위

주식 보유

변동

Ms. Johanna Mercier

Chief Commercial Officer

104.55K

+0.38%

Dr. Jacqueline K. Barton, Ph.D.

Independent Director

26.06K

+5.82%

Mr. Anthony (Tony) Welters, J.D.

Lead Independent Director

11.75K

+12.90%

Ms. Kelly A. Kramer

Independent Director

1.34K

Mr. Harish Manwani

Independent Director

Mr. Andrew D. (Andy) Dickinson

Chief Financial Officer

Mr. Daniel P. O'Day

Chairman of the Board, Chief Executive Officer

Dr. Sandra J. Horning, M.D.

Independent Director

Mr. Javier J. Rodriguez

Independent Director

Dr. Jeffrey A. (Jeff) Bluestone, Ph.D.

Independent Director

이름

이름/직위

직위

주식 보유

변동

Ms. Johanna Mercier

Chief Commercial Officer

104.55K

+0.38%

Dr. Jacqueline K. Barton, Ph.D.

Independent Director

26.06K

+5.82%

Mr. Anthony (Tony) Welters, J.D.

Lead Independent Director

11.75K

+12.90%

Ms. Kelly A. Kramer

Independent Director

1.34K

Mr. Harish Manwani

Independent Director

Mr. Andrew D. (Andy) Dickinson

Chief Financial Officer

수익 분석

통화: USD마지막 업데이트: Tue, Jan 6

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

FY2017

FY2016

FY2015

사업별USD

이름

수익

비율

Biktarvy

3.69B

47.46%

Descovy

698.00M

8.98%

Royalty Contract and other revenues

423.00M

5.44%

Genvoya

376.00M

4.84%

Trodelvy

357.00M

4.60%

기타

2.23B

28.68%

지역별USD

이름

수익

비율

United States

5.01B

64.45%

Europe

1.51B

19.47%

Other Locations

837.00M

10.77%

사업별

지역별

사업별USD

이름

수익

비율

Biktarvy

3.69B

47.46%

Descovy

698.00M

8.98%

Royalty Contract and other revenues

423.00M

5.44%

Genvoya

376.00M

4.84%

Trodelvy

357.00M

4.60%

기타

2.23B

28.68%

주식 보유 통계

마지막 업데이트: Fri, Feb 13

주주

주주 유형

주주

비율

The Vanguard Group, Inc.

9.71%

BlackRock Institutional Trust Company, N.A.

6.12%

State Street Investment Management (US)

4.85%

Fidelity Management & Research Company LLC

4.76%

Capital World Investors

3.45%

기타

71.11%

주주

비율

The Vanguard Group, Inc.

9.71%

BlackRock Institutional Trust Company, N.A.

6.12%

State Street Investment Management (US)

4.85%

Fidelity Management & Research Company LLC

4.76%

Capital World Investors

3.45%

기타

71.11%

주주 유형

주주

비율

Investment Advisor

55.87%

Investment Advisor/Hedge Fund

25.35%

Pension Fund

3.10%

Research Firm

2.96%

Bank and Trust

1.89%

Sovereign Wealth Fund

1.87%

Hedge Fund

1.48%

Insurance Company

0.15%

Individual Investor

0.09%

기타

7.24%

기관 주식 보유



마지막 업데이트: Thu, Jan 1

보고 기간

기관 수

보유 주식

비율

변동

2025Q4

3534

1.15B

92.30%

-3.11M

2025Q3

3433

1.13B

91.16%

+23.58K

2025Q2

3388

1.12B

90.01%

-12.02M

2025Q1

3442

1.12B

90.14%

-10.49M

2024Q4

3313

1.12B

90.13%

+4.63M

2024Q3

3207

1.10B

88.48%

-11.56M

2024Q2

3188

1.10B

88.24%

-14.37M

2024Q1

3196

1.10B

88.13%

-22.04M

2023Q4

3252

1.11B

88.75%

-8.79M

2023Q3

3190

1.10B

88.14%

-23.58M

주주 활동



이름

보유 주식

비율

변동

Chg %

날짜

The Vanguard Group, Inc.

118.39M

9.54%

-392.37K

-0.33%

Sep 30, 2025

BlackRock Institutional Trust Company, N.A.

72.73M

5.86%

+1.93M

+2.72%

Sep 30, 2025

State Street Investment Management (US)

59.09M

4.76%

-98.86K

-0.17%

Sep 30, 2025

Fidelity Management & Research Company LLC

53.80M

4.34%

+39.02K

+0.07%

Sep 30, 2025

Capital World Investors

45.18M

3.64%

-1.12M

-2.43%

Sep 30, 2025

Geode Capital Management, L.L.C.

29.93M

2.41%

+721.32K

+2.47%

Sep 30, 2025

Invesco Capital Management (QQQ Trust)

27.84M

2.24%

+1.83M

+7.02%

Dec 31, 2025

Dodge & Cox

30.13M

2.43%

-685.19K

-2.22%

Sep 30, 2025

T. Rowe Price Associates, Inc.

24.42M

1.97%

+2.87M

+13.33%

Sep 30, 2025

Capital Research Global Investors

30.01M

2.42%

-1.08M

-3.48%

Sep 30, 2025

주식 배당금



지난 5년 동안 총 15.04B USD의 배당금이 분배되었습니다.

날짜

배당금

기준일

지급일

배당락일

Feb 10, 2026

GILD.NB Interim Cash Dividend of gross USD 0.82 paid on Mar 30, 2026 going ex on Mar 13, 2026

Mar 13, 2026

Mar 30, 2026

Mar 13, 2026

Oct 30, 2025

GILD.NB Final Cash Dividend of gross USD 0.79 paid on Dec 30, 2025 going ex on Dec 15, 2025

Dec 15, 2025

Dec 30, 2025

Dec 15, 2025

Aug 07, 2025

GILD.NB Interim Cash Dividend of gross USD 0.79 paid on Sep 29, 2025 going ex on Sep 15, 2025

Sep 15, 2025

Sep 29, 2025

Sep 15, 2025

Apr 24, 2025

GILD.NB Interim Cash Dividend of gross USD 0.79 paid on Jun 27, 2025 going ex on Jun 13, 2025

Jun 13, 2025

Jun 27, 2025

Jun 13, 2025

Feb 11, 2025

GILD.NB Interim Cash Dividend of gross USD 0.79 paid on Mar 28, 2025 going ex on Mar 14, 2025

Mar 14, 2025

Mar 28, 2025

Mar 14, 2025

Nov 12, 2024

GILD.NB Final Cash Dividend of gross USD 0.77 paid on Dec 30, 2024 going ex on Dec 13, 2024

Dec 13, 2024

Dec 30, 2024

Dec 13, 2024

Aug 13, 2024

GILD.NB Interim Cash Dividend of gross USD 0.77 paid on Sep 27, 2024 going ex on Sep 13, 2024

Sep 13, 2024

Sep 27, 2024

Sep 13, 2024

Apr 26, 2024

GILD.NB Interim Cash Dividend of gross USD 0.77 paid on Jun 27, 2024 going ex on Jun 14, 2024

Jun 14, 2024

Jun 27, 2024

Jun 14, 2024

Feb 06, 2024

GILD.NB Interim Cash Dividend of gross USD 0.77 paid on Mar 28, 2024 going ex on Mar 14, 2024

Mar 15, 2024

Mar 28, 2024

Mar 14, 2024

Nov 08, 2023

GILD.NB Final Cash Dividend of gross USD 0.75 paid on Dec 28, 2023 going ex on Dec 14, 2023

Dec 15, 2023

Dec 28, 2023

Dec 14, 2023

주식 분할



날짜

배당락일

유형

비율

데이터 없음

날짜

배당락일

유형

비율

데이터 없음

KeyAI



Gilead Sciences Inc

자세한 내용은 Gilead Sciences Inc 회사

Gilead Sciences Inc 정보

Gilead Sciences Inc의 회사 임원진

수익 분석

주식 보유 통계

기관 주식 보유

주주 활동

관련 ETF

주식 배당금

주식 분할